Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8060600 | 1.00 | TSHR (0.56) | TSHRSMN1; SMN2MAPTKMT2AALDH1A1 | |
| SCHEMBL11367872 | 0.89 | — | — | |
| SCHEMBL5138597 | 0.88 | SMN1; SMN2 (0.52) | TSHRSMN1; SMN2MAPTKMT2AALDH1A1 | |
| SCHEMBL3182230 | 0.87 | — | — | |
| SCHEMBL17859667 | 0.86 | SMN1; SMN2 (0.50) | TSHRSMN1; SMN2MAPTKMT2AALDH1A1 | |
| SCHEMBL17859666 | 0.86 | SMN1; SMN2 (0.50) | TSHRSMN1; SMN2MAPTKMT2AALDH1A1 | |
| SCHEMBL3795914 | 0.86 | — | — | |
| SCHEMBL24132826 | 0.85 | EPHX1 (0.52) | TSHRSMN1; SMN2MAPTKMT2AFAAH | |
| SCHEMBL4577617 | 0.85 | TSHR (0.45) | TSHRSMN1; SMN2MAPTKMT2AALDH1A1 | |
| SCHEMBL4577611 | 0.85 | TSHR (0.45) | TSHRSMN1; SMN2MAPTKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122025784-A | Flame-retardant polymer electrolyte material based on Lewis acid-base synergistic regulation and preparation method thereof | 石河子大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260125496-A1 | MONOMERS AND CURABLE COMPOSITIONS FOR CRYSTALLINITY CONTROL IN POLYMERIC MATERIALS FOR 3D-PRINTED DENTAL DEVICES | ALIGN TECHNOLOGY INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4049841-B1 | HYBRID RESIN COMPOSITION | CUBICURE GMBH (AT) | 2026-03-18 | — | — | EP | claimed |
| EP-4704757-A1 | SEMICRYSTALLINE SULFUR CONTAINING POLYMERS FOR ORTHODONTIC APPLICATIONS | Align Technology, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4174115-B1 | RADIATION CROSS-LINKING BOOSTERS FOR ALIPHATIC POLYAMIDES | THUERINGISCHES INST FUER TEXTIL UND KUNSTSTOFF FORSCHUNG E V (DE) | 2025-12-10 | — | — | EP | claimed |
| WO-2025235302-A1 | POLYMERIC COMPOSITIONS THAT INCLUDE UREA REPEAT GROUPS | PPG INDUSTRIES OHIO, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| EP-4073172-B1 | METHOD FOR PREPARING AN INVERSE LATEX FOR COSMETIC COMPOSITION COMBINING EDDS AS SEQUESTERING AGENT AND A POLYELECTROLYTE COMPRISING AMPS AND ACRYLAMIDE | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2025-11-12 | — | — | EP | claimed |
| US-20250319013-A1 | THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2025-10-16 | — | — | US | claimed |
| US-12390987-B2 | Hybrid resin composition for the 3D-printing of objects | CUBICURE GMBH (AT) | 2025-08-19 | — | — | US | claimed |
| CN-114650803-B | Cosmetic composition in the form of compacted, impact-resistant powder | 化工产品开发公司SEPPIC | 2025-03-14 | — | — | CN | claimed |
| WO-1994009000-A1 | QUINOXALINEDIONE DERIVATIVES AS EAA ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1994-04-28 | — | — | WO | claimed |
| EP-0186361-B2 | Thickeners for thickening aqueous media | SCOTT BADER CO (GB) | 1994-04-27 | — | — | EP | claimed |
| WO-1993025386-A1 | THERMALLY RESISTANT GLASS ARTICLE | ENSIGN-BICKFORD COATINGS COMPANY (US) | 1993-12-23 | — | — | WO | claimed |
| US-5225473-A | For bioelectrodes | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-07-06 | — | — | US | claimed |
| EP-0186361-B1 | THICKENERS FOR THICKENING AQUEOUS MEDIA | SCOTT BADER COMPANY LIMITED (GB) | 1990-09-12 | — | — | EP | claimed |
| EP-0186361-A2 | Thickeners for thickening aqueous media | SCOTT BADER COMPANY LIMITED (GB) | 1986-07-02 | — | — | EP | claimed |
| US-4485031-A | FOR REACTION INJECTION MOLDING POLYURETHANES | THE DOW CHEMICAL COMPANY (US) | 1984-11-27 | — | — | US | claimed |
| EP-0029891-B1 | PAINT COMPOSITIONS HAVING WET ADHESION CHARACTERISTICS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1983-08-17 | — | — | EP | claimed |
| US-4302375-A | VINYL ACETATE LATEX WITH COPOLYMERIZED DIALLYL UREA | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1981-11-24 | — | — | US | claimed |
| EP-0029891-A2 | Paint compositions having wet adhesion characteristics | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1981-06-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125496-A1 | MONOMERS AND CURABLE COMPOSITIONS FOR CRYSTALLINITY CONTROL IN POLYMERIC MATERIALS FOR 3D-PRINTED DENTAL DEVICES | SMCHD1, SMC4, SMC3 | TSHR 2031/4885SMN1; SMN2 1219/4885MAPT 2819/4885 |
| US-20250319013-A1 | THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS | PHOSPHO1, ELOVL5, PARG | TSHR 4044/4885SMN1; SMN2 3576/4885MAPT 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.